Business Practice

The Chinese pharmaceutical market is already more advanced than many in the West imagine – and it only looks set to go in one direction.

With the US back to divided government, the US pharma industry could be the number one target for politicians.

As ever, our industry will have to deal with its fair share of sociopolitical “fun” in 2019. But what can we do?

2019 Power List nominations close in just one month. Who’s in the running? Well, that’s up to you…

Mega mergers, state-of-the-art stem cell facility and humorous pharmaceutical ads… What’s new for pharma in business?

Sitting Down With… Stanley Crooke, Chairman of the Board & Chief Executive Officer at Ionis Pharmaceuticals.

Rather than fearing the unknown, the concept of optionality can help you better manage it.

Oscars of science, drug shortage reporting requirements, and a new gene therapy... What’s new for pharma in business?

Sitting Down With... Vivek Sharma, CEO of Piramal Pharma Solutions.

The business of making biopharmaceuticals is expensive – so the more data you have to back up decisions, the better.